DECanBio project, coordinated by the Exploring the Dynamics of Proteomes laboratory plans to explore and evaluate new biomarker candidates for the bladder cancer by analyzing urine proteome of patients, as well as the transcriptome of bladder tumors. Following this work, a new bladder cancer screening test should be developed.